My Insurance Won’t Cover GLP-1 Drugs. What Now?

6 Min Read
6 Min Read
Roughly 1 in 8 American adults has tried a GLP-1 remedy, however the majority of customers discontinue therapy, particularly when the out-of-pocket prices are excessive.

Within the complicated world of well being care and insurance coverage, it pays to pursue each doable possibility. You may dispute insurance coverage denials, however the value a pharmacy affords will not be essentially the bottom value you could find.

seek for reductions

For years, the price of semaglutide and tirzepatide was extensively reported to be round $1,000 monthly. Whereas money costs should be excessive at your native pharmacy counter, drug firms have just lately made their merchandise out there at a lot decrease costs in different methods.

Lilly (Mounjaro, Zepbound), the maker of tirzepatide, at the moment affords the drug for $349 to $499 monthly when bought on its web site or at Walmart.

Lilly’s FDA-approved GLP-1 pill, Foundayo, can be out there for buy on Lilly’s direct-to-consumer web site. Relying on dosage, Foundayo prices about $149 to $299 monthly with out insurance coverage.

Novo Nordisk, the maker of semaglutide (Ozempic, Wegovy), affords most doses of the burden loss and diabetes drug for $149 to $299 monthly, and injectables for $349 to $499 monthly. New decrease costs can be found on the producer’s web site or via choose companions like WW and Costco.

In November 2025, each producers introduced that costs for medicines bought via government-run web sites would change into even decrease within the coming years.

See also  Living With Heart Disease? Don’t Skip These Vaccines, Cardiology Group Says

In some circumstances, these low-cost drugs could also be administered in vials and syringes or in tablet type slightly than in easy-to-use prefilled injection pens.

Moreover, drug firms could provide coupons and financial savings playing cards that may considerably cut back your out-of-pocket prices over the course of a 12 months. Nevertheless, not everybody can take part in these applications, nor can they be used indefinitely.

Disputing Lack of Protection

Bridget Roberts, 37, received re-admission to Zepbound via persistence. It began when the Pottsgrove, Pennsylvania, resident obtained a letter saying her insurance coverage firm now not lined GLP-1.

“At first, I felt like I used to be doomed,” she says. “One thing was lastly beginning to click on and I used to be extra alive than ever, they usually wished to take that away from me.”

Roberts pushed again. She referred to as a number of instances to enchantment, however was advised a distinct story every time. Her persistence lastly paid off. She spoke with a consultant from her insurance coverage firm who advised her to hunt a brand new pre-authorization from her physician. This approval could also be required by the physician earlier than the insurance coverage firm agrees to cowl the therapy.

“It was like she was talking in code, like she knew one thing I did not know,” Roberts says. She and her physician had been equally confused as a result of she already had prior authorization, however when her physician filed a brand new request, her remedy was authorized.

Swap diagnostics

Different GLP-1 customers have been in a position to keep insurance coverage protection by altering the prognosis indicated on their prescription.

See also  Which Drinks to Sip and Skip While Fasting

“Many GLP-1s are FDA-approved for functions past simply weight reduction, reminiscent of sort 2 diabetes, cardiovascular danger discount, and even stroke prevention in sure populations,” says Supriya Rao, M.D., an weight problems doctor and director of medical weight reduction at Lowell Common Hospital in Lowell, Massachusetts. Some are additionally authorized for a liver illness often known as metabolic dysfunction-associated steatohepatitis (MASH).

In case your insurance coverage firm cancels protection for a weight reduction drug, you could have protection for a similar drug for an additional situation reminiscent of sleep apnea, coronary heart illness, or MASH. A brand new prescription for a brand new situation “may make the distinction between full denial and full protection,” Dr. Rao says.

Dr. Brianna Johnson-Lovett, an endocrinologist at Nebraska Medication and director of the American Board of Weight problems Medication, affords some examples. “If somebody has heart problems and is overweight or chubby, we are able to prescribe Wigoby based mostly on that indication,” says Dr. Johnson-Lovett. “Folks with reasonable to extreme obstructive sleep apnea and weight problems could be prescribed Zepbound for his or her signs.”

Nevertheless, switching diagnoses doesn’t assure protection. “Even when the FDA’s indications for prescribing the drug are met, insurance coverage could resolve to not cowl the drug,” Johnson-Lovett says.

Share This Article
Leave a comment